About CATALIS
CATALIS is a company based in Montreal (Canada) founded in 2017.. CATALIS has raised $1.18 million across 1 funding round from investors including Merck, AbbVie and Pfizer. CATALIS offers products and services including FAST TRACK Evaluation Service, Personalized Support Service, and Clinical Trials Quebec. CATALIS operates in a competitive market with competitors including MCRA, Blue Matter Consulting, CHDR, PharmAla Biotech and Aptus Clinical, among others.
- Headquarter Montreal, Canada
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.18 M (USD)
in 1 rounds
-
Latest Funding Round
$1.18 M (USD), Seed
Jun 03, 2019
-
Investors
Merck
& 7 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CATALIS
CATALIS offers a comprehensive portfolio of products and services, including FAST TRACK Evaluation Service, Personalized Support Service, and Clinical Trials Quebec. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Accelerates authorization for clinical trials in Quebec
Offers tailored assistance for clinical research stakeholders
Facilitates tools and resources for conducting clinical trials
Funding Insights of CATALIS
CATALIS has successfully raised a total of $1.18M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.18 million completed in June 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $1.2M
-
First Round
First Round
(03 Jun 2019)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2019 | Amount | Seed - CATALIS | Valuation | GSK , Pfizer |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in CATALIS
CATALIS has secured backing from 8 investors, including institutional investors. Prominent investors backing the company include Merck, AbbVie and Pfizer. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
Founded Year | Domain | Location | |
|
Pharmaceutical products for treating multiple diseases are provided.
|
Founded Year | Domain | Location | |
|
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by CATALIS
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - CATALIS
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Catalis Comparisons
Competitors of CATALIS
CATALIS operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MCRA, Blue Matter Consulting, CHDR, PharmAla Biotech and Aptus Clinical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of regulatory, quality assurance and market access services to biopharma sector
|
|
| domain | founded_year | HQ Location |
Provider of consulting services focused for clinical drug development
|
|
| domain | founded_year | HQ Location |
Early-stage clinical drug research consulting services are provided.
|
|
| domain | founded_year | HQ Location |
Biomanufacturing, regulatory, and financial services are provided by PharmAla Biotech.
|
|
| domain | founded_year | HQ Location |
Auxiliary clinical development services are provided to biopharmaceutical firms.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Catalis
Frequently Asked Questions about CATALIS
When was CATALIS founded?
CATALIS was founded in 2017 and raised its 1st funding round 2 years after it was founded.
Where is CATALIS located?
CATALIS is headquartered in Montreal, Canada. It is registered at Montreal, Quebec, Canada.
Is CATALIS a funded company?
CATALIS is a funded company, having raised a total of $1.18M across 1 funding round to date. The company's 1st funding round was a Seed of $1.18M, raised on Jun 03, 2019.
What does CATALIS do?
CATALIS was founded in 2017 in Montreal, Canada, as a provider of consulting services in the biopharmaceutical sector. Operations center on clinical drug development, with support for phase I, II, and III trials. Expertise is applied to pharmacology, biomarkers, and biopharmaceutical devices, assisting clients in regulatory and operational aspects of drug advancement. Services are delivered to facilitate efficient trial execution and development processes.
Who are the top competitors of CATALIS?
CATALIS's top competitors include S-Cubed, Blue Matter Consulting and PharmAla Biotech.
What products or services does CATALIS offer?
CATALIS offers FAST TRACK Evaluation Service, Personalized Support Service, and Clinical Trials Quebec.